Main Article Content

Maha Rahim Qureshi
Ashok Kumar
Dev Anand
FNU Anam
Dr. Lareb Gul
Dr. Ugal Kishore
Dr. Muhammad Ayoob Memon
FNU Partab
Mohsin Ali
Sona Kumari


COVID-19, Patients, Manifestation, Lesions


Background: Cutaneous manifestations have been increasingly recognized as potential symptoms of COVID-19. Understanding the spectrum of dermatological findings associated with COVID-19 can aid in early recognition, diagnosis, and appropriate management of affected individuals. This structural abstract provides a concise overview of the cutaneous manifestations observed in patients with COVID-19.

Methods: A comprehensive review of published literature and relevant studies was conducted using electronic databases. The search included articles reporting on cutaneous manifestations associated with COVID-19. Data regarding the types of skin lesions, their clinical presentations, and their temporal relationship to COVID-19 were extracted and analyzed.

Results: A total of 100 studies met the inclusion criteria, encompassing a substantial number of COVID-19 patients with cutaneous manifestations. The analysis revealed a diverse range of skin lesions, including erythematous maculopapular rashes, vesicular eruptions, urticaria, livedo reticularis, and acral lesions such as chilblain-like lesions and vesicular-pustular eruptions. Some lesions demonstrated a characteristic distribution pattern, such as the acral distribution observed in COVID-19-associated chilblain-like lesions. The timing of skin manifestations varied, with some occurring before, during, or after the onset of respiratory symptoms.

Conclusion: Cutaneous manifestations are increasingly recognized as potential markers of COVID-19. Dermatological findings can serve as valuable clinical clues in identifying and managing individuals with COVID-19, particularly in the absence of typical respiratory symptoms. Healthcare providers should be aware of the various skin manifestations associated with COVID-19 and consider them in the diagnostic workup of suspected cases. Further research is needed to elucidate the underlying mechanisms and determine the clinical significance of these cutaneous manifestations in COVID-19 patients.

Abstract 452 | pdf Downloads 72


1. Freeman EE, McMahon DE, Lipoff JB, et al. Cutaneous manifestations of COVID-19: a preliminary review. J Am Acad Dermatol. 2020;83(3):e211-e212. doi:10.1016/j.jaad.2020.04.018
2. Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
3. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212-e213. doi:10.1111/jdv.16387
4. Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M. Comment on "Cutaneous manifestations in COVID-19: a first perspective" by Recalcati S. J Eur Acad Dermatol Venereol. 2020;34(6):e299-e300. doi:10.1111/jdv.16474
5. Sachdeva M, Gianotti R, Shah M, et al. Cutaneous manifestations of COVID-19: report of three cases and a review of literature. J Dermatol Sci. 2020;98(2):75-81. doi:10.1016/j.jdermsci.2020.04.011
6. Conforti C, Dianzani C, Agozzino M, et al. Cutaneous manifestations in confirmed COVID-19 patients: a systematic review. Biology (Basel). 2020;9(12):449. doi:10.3390/biology9120449
7. Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280-285. doi:10.1016/j.jaad.2020.04.044
8. Alramthan A, Aldaraji W. Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East. Clin Exp Dermatol. 2020;45(6):746-748. doi:10.1111/ced.14243A
9. Singh H, Kaur H, Singh K, Sen CK. Cutaneous Manifestations of COVID-19: A Systematic Review. Adv Wound Care (New Rochelle). 2021 Feb;10(2):51-80. doi: 10.1089/wound.2020.1309. Epub 2020 Oct 19. PMID: 33035150; PMCID: PMC8020517.
10. Muhammad A, Iftikhar N, Mashhood A, Virdi G, Ud Din H, Akbar A, Ahmad B, Khalid A. Dermatological Manifestations of COVID-19 in Patients Reporting to a Tertiary Care Hospital in Rawalpindi, Pakistan. Cureus. 2021 Oct 22;13(10):e18973. doi: 10.7759/cureus.18973. PMID: 34820228; PMCID: PMC8606119.
11. Algorithm for the classification of COVID-19 rashes. Ortega-Quijano D, Jimenez-Cauhe J, Selda-Enriquez G, Fernandez-Guarino M, Fernandez-Nieto D. J Am Acad Dermatol. 2020;83:0–4
12. Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients. Piccolo V, Neri I, Filippeschi C, et al. J Eur Acad Dermatol Venereol. 2020;34:0–3
13. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries. Freeman EE, McMahon DE, Lipoff JB, et al. J Am Acad Dermatol. 2020;83:486–492.
14. Hameed S, Elbaaly H, Reid CEL, et al.. Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. Radiology 2020:202543
15. Panupattanapong S, Brooks EB. New spectrum of COVID-19 manifestations in children: kawasaki-like syndrome and hyperinflammatory response. Cleve Clin J Med 2020. [Epub ahead of print]; DOI: 10.3949/ccjm.87a.ccc039
16. Ghafoor, Rabia, et al. "Cutaneous Manifestations of Coronavirus Disease 2019." Journal of Cosmetic Dermatology, vol. 21, no. 9, 2022, pp. 3667-3672,
17. Pouletty M, Borocco C, Ouldali N, et al.. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis 2020;79:999–1006
18. Riollano-Cruz M, Akkoyun E, Briceno-Brito E, et al.. Multisystem inflammatory syndrome in children (MIS-C) related to COVID-19: a New York City experience. J Med Virol 2020. [Epub ahead of print]; DOI: 10.1002/jmv.26224
19. Garcia-Garcia ML, Calvo Rey C, Pozo Sanchez F, et al.. [Human bocavirus infections in Spanish 0–14 year-old: clinical and epidemiological characteristics of an emerging respiratory virus]. An Pediatr (Barc). 2007;67:212–219

Most read articles by the same author(s)